CRON logo

Cronos Group Inc. Stock Price

TSX:CRON Community·CA$1.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 16 Fair Values set on narratives written by author

CRON Share Price Performance

CA$4.53
1.18 (35.22%)
CA$4.68
Fair Value
CA$4.53
1.18 (35.22%)
3.1% undervalued intrinsic discount
CA$4.68
Fair Value
Price CA$4.53
AnalystConsensusTarget CA$4.68
AnalystHighTarget CA$6.00
AnalystLowTarget CA$3.45

CRON Community Narratives

·
Fair Value CA$4.68 3.1% undervalued intrinsic discount

GrowCo Capacity And Global Markets Will Unlock Potential

0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
·
Fair Value CA$6 24.5% undervalued intrinsic discount

Global Cannabis Legalization Will Expand Wellness And Medicine Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value CA$3.45 31.3% overvalued intrinsic discount

Regulatory Shifts In Israel And Germany Will Hinder Cannabis Growth

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
CA$6
24.5% undervalued intrinsic discount
Revenue
16.66% p.a.
Profit Margin
20.51%
Future PE
29.18x
Price in 2029
CA$7.24
CA$3.45
31.3% overvalued intrinsic discount
Profit Margin
35.27%
Future PE
16.21x
Price in 2029
CA$4.15

Trending Discussion

No trending discussion available.

Updated Narratives

CRON logo

CRON: Buybacks And Higher Multiple Will Support A Stronger Outlook

Fair Value: CA$6 24.5% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CRON logo

CRON: Brand Strength And Rescheduling Tailwinds Will Support Future Upside

Fair Value: CA$4.68 3.1% undervalued intrinsic discount
10 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CRON logo

CRON: Partial Rescheduling Expectations Will Constrain Future Earnings Power

Fair Value: CA$3.45 31.3% overvalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

1 Risk
3 Rewards

Cronos Group Inc. Key Details

US$179.1m

Revenue

US$102.1m

Cost of Revenue

US$77.0m

Gross Profit

US$7.1m

Other Expenses

US$70.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.19
43.02%
39.08%
0%
View Full Analysis

About CRON

Founded
n/a
Employees
610
CEO
Michael Gorenstein
WebsiteView website
thecronosgroup.com

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

Recent CRON News & Updates

Narrative Update Aug 09

CRON: Buybacks And Higher Multiple Will Support A Stronger Outlook

Analysts have increased their Cronos Group price target by CA$1 to CA$6, reflecting updated assumptions regarding fair value, discount rate, growth, and margins following recent research updates. What’s in the News for Cronos Group Cronos Group announced a share repurchase program that allows the company to buy back up to 18,712,918 shares for $50 million.

Recent updates

No updates